Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



Bevacizumab in small cell lung cancer


Journal article


Giandomenico Roviello, Navid Sobhani, Daniele Generali
Annals of Translational Medicine, vol. 5(17), 2017, p. 361

DOI: 0.21037/atm.2017.06.44

Cite

Cite

APA   Click to copy
Roviello, G., Sobhani, N., & Generali, D. (2017). Bevacizumab in small cell lung cancer. Annals of Translational Medicine, 5(17), 361. https://doi.org/0.21037/atm.2017.06.44


Chicago/Turabian   Click to copy
Roviello, Giandomenico, Navid Sobhani, and Daniele Generali. “Bevacizumab in Small Cell Lung Cancer.” Annals of Translational Medicine 5, no. 17 (2017): 361.


MLA   Click to copy
Roviello, Giandomenico, et al. “Bevacizumab in Small Cell Lung Cancer.” Annals of Translational Medicine, vol. 5, no. 17, 2017, p. 361, doi:0.21037/atm.2017.06.44.


BibTeX   Click to copy

@article{giandomenico2017a,
  title = {Bevacizumab in small cell lung cancer},
  year = {2017},
  issue = {17},
  journal = {Annals of Translational Medicine},
  pages = {361},
  volume = {5},
  doi = {0.21037/atm.2017.06.44},
  author = {Roviello, Giandomenico and Sobhani, Navid and Generali, Daniele}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in